Skip to main content
. 2020 Jun 5;64(3):235–242. doi: 10.20945/2359-3997000000242

Figure 1. Distribution of the results of the nonalcoholic fatty liver disease (NALFD) score in participants in the polycystic ovary syndrome (PCOS) group with hepatic steatosis (n = 26).

Figure 1